GLAXO TO OFFER PRICE DISCOUNTS TO PUBLIC HEALTH CLINICS
GLAXO TO OFFER PRICE DISCOUNTS TO PUBLIC HEALTH CLINICS RESEARCH TRIANGLE PARK, N.C., Feb. 4 /PRNewswire/ -- Glaxo Inc.
announced today that it would offer price discounts to public health clinics serving the poor, extending its effort to ensure patients' access to its medicines regardless of ability to pay.
Since 1984, under the company's indigent patient program, Glaxo has been providing its drugs without charge to patients who cannot afford to pay for them. Now, in another effort to ensure the accessibility of its prescription drugs, Glaxo will offer 15 percent discounts to qualifying clinics funded under the Public Health Service Act, including community health centers, migrant health centers and centers serving the homeless. To qualify for the discounts, the clinics are asked to purchase medicines directly from Glaxo and assure that all Glaxo products are available to patients. The program becomes effective May 1. The discounts will apply to outpatient prescription drugs purchased by the centers for patients not covered by Medicaid or other programs for the indigent and elderly that already receive discounts from Glaxo. The clinics serve about 6 million people annually. Savings to the public health service clinics are expected to be about $10 million a year. Glaxo also reconfirmed its policy to keep price increases in line with the general inflation rate. Glaxo's pledge to limit price increases to the general inflation rate continues a trend begun by the company in the 1990/91 fiscal year. In that year, the overall price increase for all Glaxo products was 3.7 percent -- well below the increase in the general Consumer Price Index of 4.6 percent. Including the Medicaid rebates in the calculation, Glaxo's overall increase for fiscal 1990/91 was 1.5 percent. The company said it will continue its work to ensure that no patients are denied medicines based on their economic status. -0- 2/4/92 /CONTACT: Rick Sluder, Corporate Communications, Glaxo Inc., 919-248-2839/ CO: Glaxo Inc. ST: North Carolina IN: MTC HEA SU: PDT
DF -- CH004 -- 6608 02/04/92 10:45 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Feb 4, 1992|
|Previous Article:||NATIONAL CENTER FOR SUPERCOMPUTING APPLICATIONS (NCSA) ORDERS A CONVEX C3880 SUPERCOMPUTER|
|Next Article:||DELL CONTINUES AGGRESSIVE PRICING STRATEGY IN '92; SYSTEM PRICES REDUCED BY UP TO 38 PERCENT; REDUCTIONS AS HIGH AS 47 PERCENT ON PERIPHERALS|